Clinical trial
Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea
NCT01976624 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- January 31, 2014
- Enrollment
- 756 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.